Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
PXG Marks 5th Year of Women’s Golf Month with Expanded #SheGolfs Invitation to Play Amid Historic Surge in Women’s Golf Participation
-
KONTAKTUM (former Berger Kommunkation) launches SignalDesk to Power Europe’s Top Wellness Brands
-
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 Months with Individualized Cancer Vaccine TG4050
-
Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025
-
OFL Commemorates First Official Injured Workers’ Day and Demands Recognition Be Met with Justice
-
Camfil Releases 2024 Sustainability Report Emphasizing Transparency, Circularity, and Climate Action
-
After 40 Years, Ontario Finally Recognizes Injured Workers’ Day
-
Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO
-
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
-
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
-
Mining Without Machines: ZA Miner Launches Seamless Cloud Solution for Daily Crypto Rewards
-
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
-
ZA Miner Launches An AI-Driven Mining Protocol Ensuring Users Earn the Highest Crypto Rewards
-
Breaking the Paycheck-to-Paycheck Cycle: Bitcoin Solaris Presale Phase 5 Ends in Hours—Mobile Mining App Nears Launch
-
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
-
StreetLeaf Plants its 10,000th Light in Advance of Hurricane Season
-
NIO Inc. Provides May 2025 Delivery Update
-
XPENG Announces Vehicle Delivery Results for May 2025
-
Li Auto Inc. May 2025 Delivery Update
-
Skills Canada National Competition 2025, in Regina, Wraps up with a Celebration of National Skills Champions!
-
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment o
-
PFM CRYPTO Launches New 2-Day XRP Cloud Mining Contract in Response to The Surge in Demand from Short-Term Income Investors
-
GA (Int’l) Capital Management Announces Launch of Communication Hubs
-
XRP News: XenDex Presale Ends In 12 Hours, Join Presale Before $XDX Exchange Listing
-
AI Meets XRPL: Nimanode’s $NMA Presale Gains Momentum as AI Agents Set to Transform Web3 Automation
-
XRP News: $XDX Token Developed on XRP Nears Presale End in Just 12 Hours as Analysts Predict Major Surge Upon Exchange Listing
-
Afognak Native Corporation Hires New CEO
-
Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich
-
JAMining Expands FCA-Regulated Cloud Mining Services Amid Surging Crypto Market Activity
-
Double Deposit Bonus, $50 Welcome Bonus & No-KYC 100x Leverage Trading Now Available on BexBack
-
Double Deposit Bonus, $50 Welcome Bonus & No-KYC 100x Leverage Trading Now Available on BexBack
-
Direct Energy Regulated Services Announces Natural Gas Rates for June 2025
-
USW: Trump’s 50% tariffs on steel and aluminum are a direct attack on Canadian jobs — Ottawa must act now
-
Crypto Bubbles Come and Go: How Bitcoin Solaris’s Technology Aims for Stable, Long-Term Appreciation
-
Dignity Made Launches to Fight Trafficking with Ethical Coconut Oil
-
New data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
-
Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing
-
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
-
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
-
Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025
-
Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
-
ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025
-
Maryland Student Wins NFTE Capital Youth Entrepreneurship Challenge
-
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
-
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
-
Investors Mobilize to ‘Free Linqto’ Amid Concerns of Mismanagement
-
WithSecure has completed the transaction of Cyber security consulting divestment to Neqst
-
Trans Mountain Corporation Releases First Quarter 2025 Financial Results
-
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
-
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New
